Drugs / Iphosphamid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05049473 | Jan 2014 → Jan 2024 | Burkitt lymphoma | PETHEMA Foundation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iphosphamid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05049473 ↗ |
| Route | Intravenous | “800 mg/m² IV in 1 hour.” NCT05049473 ↗ |